Longevity Health Holdings Inc. (XAGE) 은(는) 상장 기업입니다 헬스케어 섹터의 바이오 산업에서 운영. 본사 소재지는 Pittsburgh, PA, 미국. 현재 CEO는 J. Ram Ajjarapu.
XAGE 을(를) 보유 IPO 날짜 2021-09-23, 15 명의 정규직 직원, 에 상장 Other OTC, 시가총액 $528.95K.
Longevity Health Holdings Inc focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.
